{"@id":"https://bioecon.ru/technology/autologous-muscle-precursor-cell-therapy/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/autologous-muscle-precursor-cell-therapy/","json":"https://cn.bioecon.ru/api/v1/technology/autologous-muscle-precursor-cell-therapy/index.json"},"id":"autologous-muscle-precursor-cell-therapy","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/abinopharm/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/integriculture/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/"]},"maturity":7,"name":"自体骨骼肌前体细胞（MPC）原位再生细胞疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"股外侧肌局部微创穿刺采样"},{"n":2,"title":"成肌性CD56+卫星细胞特异纯化"},{"n":3,"title":"无血清生物反应器维持干性扩增"},{"n":4,"title":"经尿道超声高精度注射括约肌原位再生"}],"summary":"通过股四头肌微针穿刺采集自体组织，经GMP严格分离纯化出CD56+骨骼肌卫星细胞/肌前体细胞（MPC），在超声实时精细引导下注射入尿道括约肌缺损区，原位再生横纹肌纤维根治压力性尿失禁。","url":"/technology/autologous-muscle-precursor-cell-therapy/","verified":"2026-11-22"}